Skip to content

Insider · CIK 0001699305

Orlando Oliveira

officer

Files at ZBIO (Zenas BioPharma, Inc.). First filing -, latest -.

In brief

Orlando Oliveira files SEC Form 4 as officer at ZBIO (Zenas BioPharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Orlando Oliveira has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 2 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 10, 2025ZBIO
Zenas BioPharma, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+100,000$0.00$0100,000Jun 12, 2025
Dec 16, 2024ZBIO
Zenas BioPharma, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+7,775$0.00$07,775Dec 18, 2024

Questions about Orlando Oliveira

Answered from the filings on this page, as of the latest one.

Is Orlando Oliveira buying or selling?

Orlando Oliveira has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Orlando Oliveira's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Orlando Oliveira has 0.

Where does Orlando Oliveira file Form 4?

Orlando Oliveira has filed Form 4 at ZBIO (Zenas BioPharma, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Orlando Oliveira: insider trades and track record | InsiderTell